OREANDA-NEWS. On March 20, 2007 Industrial Biotechnology Corporation (PINKSHEETS: IBTY) (IBC), a company dedicated to new biotechnologies and innovations in the chemical industry, announced that members of its Senior Scientific and Management Team will be attending The Fourth Annual World Congress on Industrial Biotechnology and Bioprocessing in Orlando, Florida on March 21-24, reported the press-centre of  Industrial Biotechnology Corporation.

The World Congress on Industrial Biotechnology and Bioprocessing is the premiere gathering of thought leaders, investors, researchers and business executives in industrial biotechnology, bioenergy and bioprocessing. The conference will provide IBC an opportunity to showcase its proprietary and licensed technologies, including the recently announced ALCHEMx Bio Renewable Production Platform™; a proprietary bioprocesses to convert ethanol into various chemical feedstock compounds.

"During this conference, we will be discussing IBC's ethanol related and derivative technologies as well as our existing biotechnologies and proprietary ALCHEMx Production Platforms. We will be looking to forge and enhance relationships and partnerships with companies that possess complimentary technologies or capabilities in order to jointly capitalize on a rapidly growing bio-renewable chemicals market," said Gary Howell, VP Business Development and Scientific Operations.

IBC will be presenting its biotechnologies and conducting exploratory meetings with potential business partners, peers, investors and industry media throughout the conference dates. Interested parties are encouraged to contact IBC in advance of the conference to pre-set specific meeting times.

About Industrial Biotechnology Corporation
Industrial Biotechnology Corporation (IBC) enables the biological production of chemicals through a combination of licensed patents, intellectual property and proprietary systems. We accomplish this through our ALCHEMx™ Productions Platforms, which are a systematic, streamlined approach to biologically manufacture chemicals more efficiently, at significantly lower costs, and with substantially lower environmental impact than traditional methods. IBC and its partners plan to produce and market new and established biologically produced chemicals to the pharmaceutical, bio-energy, agricultural, biopesticides, fine chemicals, flavors and fragrances, cosmeceuticals, biomaterials and biopolymer industries.